Yu‐Hsuan Lan

602 total citations
37 papers, 495 citations indexed

About

Yu‐Hsuan Lan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu‐Hsuan Lan has authored 37 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu‐Hsuan Lan's work include Drug Transport and Resistance Mechanisms (7 papers), Natural product bioactivities and synthesis (6 papers) and Prostate Cancer Treatment and Research (6 papers). Yu‐Hsuan Lan is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Natural product bioactivities and synthesis (6 papers) and Prostate Cancer Treatment and Research (6 papers). Yu‐Hsuan Lan collaborates with scholars based in Taiwan, Vietnam and United States. Yu‐Hsuan Lan's co-authors include Bo‐Ying Bao, Lumin Chen, Hong‐Zin Lee, Te‐Ling Lu, Ta-Yuan Chang, Chin‐Chuan Hung, Shu‐Pin Huang, Wen‐Chien Ting, Chi‐Jeng Hsieh and Tsong‐Long Hwang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Yu‐Hsuan Lan

35 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Hsuan Lan Taiwan 14 251 126 126 94 56 37 495
Quan Jiang China 15 213 0.8× 115 0.9× 95 0.8× 169 1.8× 53 0.9× 30 534
Weili Min China 17 299 1.2× 92 0.7× 110 0.9× 132 1.4× 34 0.6× 26 591
Radka Václavíková Czechia 15 342 1.4× 103 0.8× 136 1.1× 204 2.2× 30 0.5× 36 608
Michael Carducci United States 13 436 1.7× 85 0.7× 126 1.0× 149 1.6× 88 1.6× 24 707
Sung‐Eun Hong South Korea 14 301 1.2× 45 0.4× 86 0.7× 61 0.6× 42 0.8× 27 467
Chung-Kwe Wang Taiwan 12 222 0.9× 63 0.5× 93 0.7× 49 0.5× 19 0.3× 12 617
Jacob Schwartzman United States 9 444 1.8× 159 1.3× 87 0.7× 50 0.5× 45 0.8× 15 551
Gennady A. Belitsky Russia 15 402 1.6× 70 0.6× 152 1.2× 114 1.2× 50 0.9× 71 649
Javid A. Dar United States 15 310 1.2× 145 1.2× 68 0.5× 64 0.7× 54 1.0× 26 495
Itishree Kaushik United States 10 435 1.7× 90 0.7× 156 1.2× 212 2.3× 30 0.5× 12 756

Countries citing papers authored by Yu‐Hsuan Lan

Since Specialization
Citations

This map shows the geographic impact of Yu‐Hsuan Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Hsuan Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Hsuan Lan more than expected).

Fields of papers citing papers by Yu‐Hsuan Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Hsuan Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Hsuan Lan. The network helps show where Yu‐Hsuan Lan may publish in the future.

Co-authorship network of co-authors of Yu‐Hsuan Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Hsuan Lan. A scholar is included among the top collaborators of Yu‐Hsuan Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Hsuan Lan. Yu‐Hsuan Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kuo, Chan‐Yen, et al.. (2023). Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPase. Pharmaceuticals. 16(2). 205–205. 10 indexed citations
5.
Chou, Yi‐Fan, et al.. (2022). Curcuminoids Inhibit Angiogenic Behaviors of Human Umbilical Vein Endothelial Cells via Endoglin/Smad1 Signaling. International Journal of Molecular Sciences. 23(7). 3889–3889. 3 indexed citations
6.
7.
Lin, Hui‐Chang, Wen‐Ping Jiang, Yu‐Hsuan Lan, et al.. (2021). Exploitation of a rod-shaped, acid-labile curcumin-loaded polymeric nanogel system in the treatment of systemic inflammation. Biomaterials Advances. 133. 112597–112597. 4 indexed citations
8.
Lan, Yu‐Hsuan, et al.. (2021). Structural insights into the substrate selectivity of α-oxoamine synthases from marine Vibrio sp. QWI-06. Colloids and Surfaces B Biointerfaces. 210. 112224–112224. 3 indexed citations
9.
10.
Lan, Yu‐Hsuan, et al.. (2019). Uncertainty under Climate Change: the Resource Cycle of Industry in Taiwan’s Offshore Islands. SHILAP Revista de lepidopterología. 117. 15–15. 1 indexed citations
11.
Chen, Chiao‐Yun, Yu‐Jung Lin, Charles C. N. Wang, et al.. (2019). Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells. Biomedicine & Pharmacotherapy. 120. 109491–109491. 22 indexed citations
12.
Lan, Yu‐Hsuan, Chia‐Hung Yen, & Yann‐Lii Leu. (2019). Chemical constituents from the aerial parts of Euphorbia formosana Hayata and their chemotaxonomic significance. Biochemical Systematics and Ecology. 88. 103967–103967. 9 indexed citations
13.
Cheng, Yu‐Jung, et al.. (2014). Antagonistic Interaction BetweenCordyceps sinensisand Exercise on Protection in Fulminant Hepatic Failure. The American Journal of Chinese Medicine. 42(5). 1199–1213. 4 indexed citations
14.
Ting, Wen‐Chien, Lumin Chen, Bang‐Jau You, et al.. (2013). Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients. International Journal of Medical Sciences. 10(8). 1022–1027. 19 indexed citations
15.
Bao, Bo‐Ying, Chun‐Nung Huang, Yeong‐Shiau Pu, et al.. (2011). Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen‐deprivation therapy. International Journal of Cancer. 130(4). 876–884. 22 indexed citations
16.
Huang, Chun‐Nung, Shu‐Pin Huang, Tzyh‐Chyuan Hour, et al.. (2011). Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer. World Journal of Urology. 31(2). 281–287. 11 indexed citations
17.
Lan, Yu‐Hsuan, et al.. (2011). The First Bis-Retrochalcone fromFissistigma latifolium. Planta Medica. 77(18). 2019–2022. 15 indexed citations
18.
Bao, Bo‐Ying, Chun‐Nung Huang, Yeong‐Shiau Pu, et al.. (2010). Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy. Clinical Cancer Research. 17(4). 928–936. 64 indexed citations
19.
Bao, Bo‐Ying, Shu‐Hung Huang, Ta-Yuan Chang, et al.. (2010). Clinical Significance of Tumor Necrosis Factor Receptor Superfamily Member 11b Polymorphism in Prostate Cancer. Annals of Surgical Oncology. 17(6). 1675–1681. 8 indexed citations
20.
Bao, Bo‐Ying, Chun‐Nung Huang, Ta-Yuan Chang, et al.. (2010). Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. Clinica Chimica Acta. 411(17-18). 1232–1237. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quan Jiang Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Radka Václavíková Breakdown of academic impact, for papers by Michael Carducci Breakdown of academic impact, for papers by Sung‐Eun Hong Breakdown of academic impact, for papers by Chung-Kwe Wang Breakdown of academic impact, for papers by Jacob Schwartzman Breakdown of academic impact, for papers by Gennady A. Belitsky Breakdown of academic impact, for papers by Javid A. Dar Breakdown of academic impact, for papers by Itishree Kaushik
Rankless by CCL
2026